Zhi Liang Chu
Company: Crossignal Therapeutics
Job title: Founder, Chief Executive Officer & Chief scientific officer
Seminars:
Targeting the Hippo Pathway Through GPCRs to Cure Inflammatory, Oncological & Autoimmune Conditions 4:30 pm
Download the Brochure to View the Session DetailsRead more
day: Day One Afternoon
Panel Discussion: How Can We Use Pre-Clinical Models to Accelerate the Translation of Hippo-Targeted Drugs Towards the Clinic? 11:15 am
Download the Brochure to View the Session DetailsRead more
day: Day Two Morning